Sagility India shares down 31.76 pc from 52-week high amid promoter stake sale

4

Mumbai, June 3 (IANS) The stock of healthcare company Sagility India Limited has declined by 31.76 per cent from its 52-week high of Rs 56.40, with the current trading price at Rs 38.49 on the National Stock Exchange (NSE).

The stock of the company, a leading global provider of technology-led business solutions and services to clients in the healthcare industry, further slipped 1.16 per cent or Rs 0.45 on Tuesday during the intra-day trading session.

Over the past few days, the stock has shown a mixed performance. It is down 2.01 per cent in the last five trading sessions and has dropped 6.58 per cent over the past one month.

On a year-to-date (YTD) basis, Sagility shares have fallen 19.68 per cent. However, over a six-month period, the stock has gained 7.97 per cent.

Investor sentiment appears to have been impacted by the promoter’s decision to reduce its stake. On May 27, shares of Sagility India hit the 5 per cent lower circuit, falling to Rs 40.70, the lowest level since May 9, after the company announced an offer for sale (OFS).

The OFS is part of a move by its promoter, Sagility B.V., to meet the minimum public shareholding requirement.

Sagility B.V. offloaded up to 15.02 per cent of its stake in the company through an Offer for Sale (OFS) conducted on May 27 and May 28.

The base offer included 34.61 crore equity shares, accounting for 7.39 per cent of the company’s paid-up capital.

An additional 35.69 crore shares (7.62 per cent) were also offered under the oversubscription option, bringing the total possible sale to 70.3 crore shares.

As of the March 2025 quarter, the promoter held approximately 82.39 per cent stake in the company. The share sale, while aimed at regulatory compliance, has led to investor caution, contributing to the recent slide in stock price.

Sagility India is a healthcare solutions provider that primarily serves US-based payers, such as health insurance companies, and healthcare providers, including hospitals and physicians.

The company offers a broad range of services, including core benefits administration, clinical support, revenue cycle management, and claims processing for payers.

–IANS

pk/na

Go to Source

Disclaimer

The information contained in this website is for general information purposes only. The information is provided by BhaskarLive.in and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.

In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.

Through this website you are able to link to other websites which are not under the control of BhaskarLive.in We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.

Every effort is made to keep the website up and running smoothly. However, BhaskarLive.in takes no responsibility for, and will not be liable for, the website being temporarily unavailable due to technical issues beyond our control.

For any legal details or query please visit original source link given with news or click on Go to Source.

Our translation service aims to offer the most accurate translation possible and we rarely experience any issues with news post. However, as the translation is carried out by third part tool there is a possibility for error to cause the occasional inaccuracy. We therefore require you to accept this disclaimer before confirming any translation news with us.

If you are not willing to accept this disclaimer then we recommend reading news post in its original language.

MGID